Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.
The aim of this work was to determine the possible inter-relationship between neuropeptide Y (NPY, a hypothalamic stimulator of feeding) and adipose tissue expression of the ob protein (a novel potent inhibitor of feeding). Such a relationship could be of importance in the maintenance of normal body weight. To this end, normal rats were intracerebroventricularly (i.c.v.) infused for 6 days with NPY. NPY infusion resulted in hyperphagia and a marked increase in adipose tissue ob mRNA levels. The effect of NPY on ob expression persisted when hyperphagia was prevented by pair-feeding, and was reversed following cessation of NPY infusion. Basal and glucose-stimulated insulinaemia were increased by i.c.v. NPY infusion compared to control values, regardless of whether animals were ad libitum-fed or pair-fed. Cessation of NPY infusion was accompanied by normalisation of insulinaemia. These changes in insulinaemia produced by i.c.v. NPY infusion paralleled the observed changes in ob expression. When normal rats were made hyperinsulinaemic-euglycaemic for 24 h, such hyperinsulinaemia also resulted in increased ob mRNA levels in white adipose tissue. This suggested that NPY-induced hyperinsulinaemia could be responsible for the upregulation of ob mRNA levels of NPY-infused rats. It is concluded that central (i.c.v.) NPY infusion increases adipose tissue ob expression, a functional relationship that is linked, at least in part, via NPY-induced hyperinsulinaemia.
Sainsbury
A
A
Laboratoires de Recherches Métaboliques, Geneva University, Switzerland.
Cusin
I
I
Doyle
P
P
Rohner-Jeanrenaud
F
F
Jeanrenaud
B
B
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D015309:Glucose Clamp Technique; D006946:Hyperinsulinism; D006963:Hyperphagia; D007263:Infusions, Parenteral; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D020738:Leptin; D009478:Neuropeptide Y / Q000008:administration & dosage / Q000494:pharmacology*; D014176:Protein Biosynthesis; D051381:Rats; D011924:Rats, Zucker; D012016:Reference Values
D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D009478:Neuropeptide Y